Stocktoria
MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-11-20
MARAVAI LIFESCIENCES HOLDINGS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 18.3% | 41.8% | 48.5% | — | — |
| Operating margin | -115.9% | -90.9% | -11.0% | 65.0% | 69.4% |
| Net margin | -70.4% | -55.9% | -41.2% | 24.9% | 22.8% |
| FCF margin | -38.1% | -8.6% | 21.0% | 58.8% | 44.3% |
| Return on assets | -17.0% | -14.4% | -8.0% | 9.6% | 9.5% |
| Return on equity | -35.1% | -25.1% | -15.1% | 24.3% | 33.4% |
| Debt / equity | 0.78× | 0.51× | 0.66× | 0.58× | 0.97× |
| Current ratio | 6.60 | 7.53 | 8.00 | 7.70 | 7.89 |
| Revenue growth | -28.3% | -10.3% | -67.3% | 10.5% | 181.3% |
Source: SEC EDGAR filings · CIK 0001823239 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.